Official press releases or scientific publications from OpenAI or Retro Biosciences

OpenAI's GPT-4b Micro Model Aids Retro Biosciences in Enhancing Yamanaka Factors for Longevity

Jan 17, 2025, 07:09 PM

OpenAI has developed a new AI model named GPT-4b micro in collaboration with Retro Biosciences, a longevity startup, to enhance the process of cell reprogramming. The model focuses on re-engineering Yamanaka factors, a set of proteins that can transform regular cells into stem cells. This collaboration, initiated a year ago, aims to increase the efficiency of cell reprogramming, which is currently a slow and inefficient process. The GPT-4b micro model has been trained to suggest modifications to the Yamanaka factors, resulting in versions that are reported to be more than 50 times as effective in preliminary tests. The project represents OpenAI's foray into scientific discovery, specifically targeting biological data and protein engineering. Retro Biosciences, backed by a $180 million investment from Sam Altman, OpenAI's CEO, is working towards extending the human lifespan by 10 years. The collaboration between OpenAI and Retro Biosciences is part of a broader effort to accelerate scientific discovery and innovation in the field of longevity science.